1.32
Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten
Published on: 2025-11-17 12:07:19 - newser.com
Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress - MarketScreener
Phio Pharmaceuticals (NASDAQ: PHIO) to Present INTASYL siRNA at Advanced Therapies USA - Stock Titan
How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulationsJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Will Phio Pharmaceuticals Corp. (44R1) stock profit from AI boomWeekly Trade Recap & High Conviction Investment Ideas - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesIndex Update & Low Volatility Stock Recommendations - newser.com
Can Phio Pharmaceuticals Corp. hit a new high this monthBond Market & Safe Capital Growth Tips - newser.com
Is Phio Pharmaceuticals Corp. stock attractive for retirement portfoliosWeekly Stock Report & Safe Capital Growth Trade Ideas - newser.com
Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025Market Risk Report & Verified Momentum Stock Watchlist - Fundação Cultural do Pará
How Phio Pharmaceuticals Corp. stock performs after earningsJuly 2025 Action & Entry Point Confirmation Alerts - Fundação Cultural do Pará
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Newsfile
Can Phio Pharmaceuticals Corp. rally from current levelsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
What drives Phio Pharmaceuticals Corp 44R1 stock priceMACD Histogram Signals & Analyze Your Portfolio Risk in Seconds - earlytimes.in
Top chart patterns to watch in Phio Pharmaceuticals Corp.Market Performance Report & Long-Term Capital Growth Ideas - newser.com
Best data tools to analyze Phio Pharmaceuticals Corp. stockEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. data2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Using economic indicators to assess Phio Pharmaceuticals Corp. potentialEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
Analyzing Phio Pharmaceuticals Corp. with multi timeframe charts2025 Price Targets & Weekly High Momentum Picks - newser.com
Its Stock Has Paid Off Big Time For Phio Pharmaceuticals Corp - setenews.com
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762 - Newsfile
Phio’s INTASYL PH-762 wins immunomodulatory solution of the year By Investing.com - Investing.com South Africa
Phio’s INTASYL PH-762 wins immunomodulatory solution of the year - Investing.com
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program - Newsfile
Phio Pharma (NASDAQ: PHIO) to present Phase 1b PH-762 skin cancer results at SITC - Stock Titan
Phio Pharmaceuticals Exercises Warrants for $13.4 Million - TipRanks
Is Phio Pharmaceuticals Corp. stock in correction or buying zoneJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
How Phio Pharmaceuticals Corp. stock benefits from tech adoptionGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
How currency fluctuations impact Phio Pharmaceuticals Corp. stockWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):